Dermatology Handbook
For UK audiences

The essential guide to product selection

Ritlecitinib (Litfulo)
Alopecia treatments Pfizer

Ritlecitinib (Litfulo)

Ritlecitinib irreversibly and selectively inhibitsjanus kinase (JAK) 3 and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family by blocking the adenosine triphosphate (ATP) binding site. In cellular settings, ritlecitinib specifically inhibits γ -common cytokines (IL-2, IL-4, IL-7, IL-15 and IL-21) signalling through JAK3-dependent common-γ chain receptors.

Indications

Treatment of severe alopecia areata in adults and adolescents 12 years of age and older

Price

  • 30 capsules, £CS

Alopecia treatments

All Alopecia treatments